Articles

Impact of luteinizing hormone suppression on hematopoietic recovery after intensive chemotherapy in patients with leukemia

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas; Division of Hematology and Oncology, American University of Beirut, Beirut
Department of Medicine, Baylor College of Medicine, Houston
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston
Department of Clinical Pharmacy, The University of Texas MD Anderson Cancer Center, Houston
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston
Division of Clinical and Translational Sciences, Department of Internal Medicine, the University of Texas McGovern Medical School at Houston, Houston, TX
Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston
Georgia Cancer Center, Augusta University, Augusta, GA
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston
Haematologica Early view Dec 3, 2020 https://doi.org/10.3324/haematol.2020.256453